WBR0252: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{WBRQuestion |QuestionAuthor={{Ochuko}} |ExamType=USMLE Step 1 |MainCategory=Microbiology |SubCategory=Infectious Disease |MainCategory=Microbiology |SubCategory=Infectious D...")
 
m (refreshing WBR questions)
 
(4 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{Ochuko}}
|QuestionAuthor= {{Ochuko}} (Reviewed by  {{YD}} and  {{AJL}})
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Microbiology
|MainCategory=Pharmacology
|SubCategory=Infectious Disease
|SubCategory=Genitourinary
|MainCategory=Microbiology
|MainCategory=Pharmacology
|SubCategory=Infectious Disease
|SubCategory=Genitourinary
|MainCategory=Microbiology
|MainCategory=Pharmacology
|SubCategory=Infectious Disease
|SubCategory=Genitourinary
|MainCategory=Microbiology
|MainCategory=Pharmacology
|MainCategory=Microbiology
|MainCategory=Pharmacology
|SubCategory=Infectious Disease
|MainCategory=Pharmacology
|MainCategory=Microbiology
|SubCategory=Genitourinary
|SubCategory=Infectious Disease
|MainCategory=Pharmacology
|MainCategory=Microbiology
|SubCategory=Genitourinary
|SubCategory=Infectious Disease
|MainCategory=Pharmacology
|MainCategory=Microbiology
|SubCategory=Genitourinary
|SubCategory=Infectious Disease
|MainCategory=Pharmacology
|MainCategory=Microbiology
|SubCategory=Genitourinary
|MainCategory=Microbiology
|MainCategory=Pharmacology
|SubCategory=Infectious Disease
|MainCategory=Pharmacology
|Prompt=A 28- year old female presents to the physicians office with complaints of vaginal odor, itching, pain and discharge. Examination shows a thin gray homogeneous fluid that is adherent to the vaginal mucosa. The labia, introitus, cervix and cervical discharge appear normal. Microscopic examination of the discharge demonstrates clue cells, with a PH of greater than 5 and gram-negative cells are dominant. What is the likely etiologic agent?
|SubCategory=Genitourinary
|Explanation=The patient in this vignette has [[Bacterial vaginosis]], caused by [[Gardnerella vaginalis]]. It is a facultative anaerobic gram-negative (pleomorphic) rod, [[catalase]] and [[oxidase]] negative. It works synergistically with other normal flora organisms like [[lactobacillus]], mobiluncus, [[bacteroides]] and [[peptostreptococcus]]. It flourishes with increased vaginal PH of > 4.5. Diagnostic clues include clue cells (these are epithelial cells covered with bacteria), PH > 5, female with thin, gray homogenous discharge. Infection also follows menses or antibiotic therapy and the Whiff test with KOH to the sample has a characteristic “fishy” amine odor. Treatment is with [[Metronidazole]] or [[Clindamycin]].
|Prompt=A 28-year-old woman presents to the physician's office with complaints of vaginal odor and discharge. A thin, homogeneous, greyish-white fluid that is adherent to the vaginal mucosa is observed on physical examination. The labia, introitus, cervix, and cervical discharge appear normal. Microscopic examination of the discharge demonstrates a pH = 5 and clue cells. The physician decides to prescribe an antimicrobial agent to treat this patient's condition. What is the mechanism of action of the prescribed antimicrobial agent?
|Explanation=[[Bacterial vaginosis]] is a polymicrobial non-sexually-transmitted disease that is caused by the replacement of the normal vaginal flora (''Lactobacilli'') with other anaerobic bacteria''. ''[[Gardnerella vaginalis]]'' is a facultative anaerobic, gram-negative (pleomorphic) rod, which is both [[catalase]]- and [[oxidase]]-negative. It is usually the causative agent responsible for the majority of cases of bacterial vaginosis. Infection by ''G. vaginalis'' may follow menses or antibiotic therapy. [[Bacterial vaginosis]] is frequently treated with [[metronidazole]] (forms free radical toxic metabolites that cause DNA injury in the bacterial cell) or [[clindamycin]] (blocks peptide translocation at 50S ribosomal subunit). Although 50% of women with bacterial vaginosis remain asymptomatic, manifestations of bacterial vaginosis include suprapubic pain, inter-menstrual spotting, abnormal menses, and malodorous vaginal discharge that produces a characteristic fishy smell upon addition of 10% KOH. The diagnostic criteria for bacterial vaginosis are:
*Presence of thin, homogeneous, adherent, greyish-white vaginal discharge
*Vaginal pH > 4.5
*Fishy amine odor upon addition of 10% KOH
*At least 20% clue cells on microscopic exam of vaginal smear. Clue cells are defined as epithelial cells whose borders are covered by bacteria


Educational Objective
|AnswerA=Inhibits ergosterol synthesis
Gardnerella vaginalis is the causative agent of bacterial vaginosis and it is a gram-negative rod seen as a thin, gray homogenous fluid with clue cells and PH greater than 4.5.
|AnswerAExp=Azoles, such as fluconazole, inhibit fungal ergosterol synthesis by blocking the conversion from lanosterol to ergosterol. Fluconazole is prescribed for vaginal candidiasis, which is in the differential diagnosis of bacterial vaginosis. Vaginal candidiasis is caused by the fungus ''Candida albicans''. It manifests as vaginal inflammation with pruritus, along with the presence of a thick, cottage-cheese, white discharge that typically has no odor. Vaginal pH is typically between 4 and 4.5, and vaginal smear shows pseudohyphae.
 
|AnswerB=Binds ergosterol and forms membrane pores that leak electrolytes
|AnswerA=Gardnerella vaginalis
|AnswerBExp=Amphotericin B binds ergosterol and forms membrane pores that leak electrolytes.  
|AnswerAExp=Gardnerella vaginalis is the causative agent of bacterial vaginosis presenting as a gray vaginal discharge with a fishy smell with clue cells and increased PH greater than 4.5 diagnostic.
|AnswerC=Inhibits dihydrofolate reductase
 
|AnswerCExp=Trimethoprim is a bacteriostatic agent that inhibits bacterial dihydrofolate reductase.
 
|AnswerD=Forms free radical toxic metabolites
|AnswerB=Candida albicans
|AnswerDExp=Metronidazole forms free radical toxic metabolites that cause DNA injury in the bacterial cell. Metronidazole is the first line antimicrobial therapy to treat bacterial vaginosis.  
|AnswerBExp=[[Candida albicans]] are yeasts with pseudohyphae and hyphae that form germ tubes at 37 degree Celsius in serum.
|AnswerE=Inhibits DNA gyrase
 
|AnswerEExp=Fluoroquinolones inhibit DNA gyrase (topoisomerase II) and topoisomerase IV.
 
|EducationalObjectives=Metronidazole forms free radical toxic metabolites that cause DNA injury in the bacterial cell. Metronidazole is the first line antimicrobial therapy to treat bacterial vaginosis.  
|AnswerC=Trichomonas vaginalis
|References=Morris M, Nicoll A, Simms I, et al. Bacterial vaginosis: a public health review. BJOG. 2001;108(5):439-50.<br>
|AnswerCExp=[[Trichomonas vaginalis]] causes foul-smelling greenish discharge, itching and burning and it is sexually transmitted. It is seen as motile trophozoites in methylene blue wet mount; and shows corkscrew motility.
First Aid 2014 page 143
|AnswerD=Neisseria gonorrhea
|RightAnswer=D
|AnswerDExp=[[Neisseria gonorrhea]] is a-gram-negative kidney bean-shaped diplococci that can cause vaginal discharge but not the characteristic thin gray vaginal discharge with a fishy odor seen in bacterial vaginosis.
|WBRKeyword=Clue cells, Bacterial vaginosis, Gardnerella vaginalis, Metronidazole, Mechanism of action, Antibiotics, Vaginal smear
|AnswerE=Chlamydia trachomatis
|AnswerEExp=[[Chlamydia trachomatis]] is not seen on gram stain and it is an obligate intracellular bacterium that cannot make ATP. In adults, it causes [[urethritis]], [[cervicitis]], [[pelvic inflammatory disease]], inclusion conjunctivitis and in neonates, it causes inclusion conjunctivitis and neonatal pneumonia.
 
 
|RightAnswer=A
|Approved=Yes
|Approved=Yes
}}
}}

Latest revision as of 23:55, 27 October 2020

 
Author [[PageAuthor::Ogheneochuko Ajari, MB.BS, MS [1] (Reviewed by Yazan Daaboul, M.D. and Alison Leibowitz [2])]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Pharmacology
Sub Category SubCategory::Genitourinary
Prompt [[Prompt::A 28-year-old woman presents to the physician's office with complaints of vaginal odor and discharge. A thin, homogeneous, greyish-white fluid that is adherent to the vaginal mucosa is observed on physical examination. The labia, introitus, cervix, and cervical discharge appear normal. Microscopic examination of the discharge demonstrates a pH = 5 and clue cells. The physician decides to prescribe an antimicrobial agent to treat this patient's condition. What is the mechanism of action of the prescribed antimicrobial agent?]]
Answer A AnswerA::Inhibits ergosterol synthesis
Answer A Explanation [[AnswerAExp::Azoles, such as fluconazole, inhibit fungal ergosterol synthesis by blocking the conversion from lanosterol to ergosterol. Fluconazole is prescribed for vaginal candidiasis, which is in the differential diagnosis of bacterial vaginosis. Vaginal candidiasis is caused by the fungus Candida albicans. It manifests as vaginal inflammation with pruritus, along with the presence of a thick, cottage-cheese, white discharge that typically has no odor. Vaginal pH is typically between 4 and 4.5, and vaginal smear shows pseudohyphae.]]
Answer B AnswerB::Binds ergosterol and forms membrane pores that leak electrolytes
Answer B Explanation AnswerBExp::Amphotericin B binds ergosterol and forms membrane pores that leak electrolytes.
Answer C AnswerC::Inhibits dihydrofolate reductase
Answer C Explanation AnswerCExp::Trimethoprim is a bacteriostatic agent that inhibits bacterial dihydrofolate reductase.
Answer D AnswerD::Forms free radical toxic metabolites
Answer D Explanation AnswerDExp::Metronidazole forms free radical toxic metabolites that cause DNA injury in the bacterial cell. Metronidazole is the first line antimicrobial therapy to treat bacterial vaginosis.
Answer E AnswerE::Inhibits DNA gyrase
Answer E Explanation AnswerEExp::Fluoroquinolones inhibit DNA gyrase (topoisomerase II) and topoisomerase IV.
Right Answer RightAnswer::D
Explanation [[Explanation::Bacterial vaginosis is a polymicrobial non-sexually-transmitted disease that is caused by the replacement of the normal vaginal flora (Lactobacilli) with other anaerobic bacteria. Gardnerella vaginalis is a facultative anaerobic, gram-negative (pleomorphic) rod, which is both catalase- and oxidase-negative. It is usually the causative agent responsible for the majority of cases of bacterial vaginosis. Infection by G. vaginalis may follow menses or antibiotic therapy. Bacterial vaginosis is frequently treated with metronidazole (forms free radical toxic metabolites that cause DNA injury in the bacterial cell) or clindamycin (blocks peptide translocation at 50S ribosomal subunit). Although 50% of women with bacterial vaginosis remain asymptomatic, manifestations of bacterial vaginosis include suprapubic pain, inter-menstrual spotting, abnormal menses, and malodorous vaginal discharge that produces a characteristic fishy smell upon addition of 10% KOH. The diagnostic criteria for bacterial vaginosis are:
  • Presence of thin, homogeneous, adherent, greyish-white vaginal discharge
  • Vaginal pH > 4.5
  • Fishy amine odor upon addition of 10% KOH
  • At least 20% clue cells on microscopic exam of vaginal smear. Clue cells are defined as epithelial cells whose borders are covered by bacteria

Educational Objective: Metronidazole forms free radical toxic metabolites that cause DNA injury in the bacterial cell. Metronidazole is the first line antimicrobial therapy to treat bacterial vaginosis.
References: Morris M, Nicoll A, Simms I, et al. Bacterial vaginosis: a public health review. BJOG. 2001;108(5):439-50.
First Aid 2014 page 143]]

Approved Approved::Yes
Keyword WBRKeyword::Clue cells, WBRKeyword::Bacterial vaginosis, WBRKeyword::Gardnerella vaginalis, WBRKeyword::Metronidazole, WBRKeyword::Mechanism of action, WBRKeyword::Antibiotics, WBRKeyword::Vaginal smear
Linked Question Linked::
Order in Linked Questions LinkedOrder::